Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 2/2015

01-06-2015 | Case Report

Enterococcus avium—a rare cause for limb loss in a type 2 diabetic patient

Authors: R. Raja Shanmugakrishnan, Venkatesan Naveenkumar, Krishnan Mahalakshmi, Padma Krishnan

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2015

Login to get access

Abstract

Enterococcus avium is a Gram-positive facultative anaerobe, found normally in the intestinal tract of human beings, pigs and chickens. E. avium has rarely been reported as a human pathogen. This bacterium has been reported previously along with other aerobes and obligate anaerobes .We report a case of diabetic foot infection with wet gangrene caused by E. avium that had led to morbidity in a 60-year-old woman due to her ignorance regarding health and self-care skills. Pus and exudates of the diabetic foot wound were processed for anaerobic cultivation, and the pure culture obtained was subjected to nested PCR using 16S rDNA universal eubacterial primers for rapid and precise identification. The clinical isolate obtained by anaerobic incubation was identified as E. avium. Aerobic culture detected scanty growth of Proteus mirabilis. This case report highlights the pathogenic potential of E. avium in anaerobiosis in the absence of obligate anaerobe accounting for serious health burden threatening patients’ quality of life.
Literature
1.
2.
go back to reference Huycke MM, Sahn DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998;4:239–49.PubMedCentralPubMedCrossRef Huycke MM, Sahn DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998;4:239–49.PubMedCentralPubMedCrossRef
3.
go back to reference Mohanty S, Kapil A, Das BK, et al. Enterococcus avium cerebellar abscess. Neurol India. 2006;54:108–9.PubMedCrossRef Mohanty S, Kapil A, Das BK, et al. Enterococcus avium cerebellar abscess. Neurol India. 2006;54:108–9.PubMedCrossRef
4.
go back to reference Pérez-Castrillon JL, Martín-Luquero M, Martín-Escudero JC, et al. Endocarditis caused by Enterococcus avium. Scand J Infect Dis. 1997;29(5):530.PubMedCrossRef Pérez-Castrillon JL, Martín-Luquero M, Martín-Escudero JC, et al. Endocarditis caused by Enterococcus avium. Scand J Infect Dis. 1997;29(5):530.PubMedCrossRef
5.
6.
go back to reference Patel R, Keating MR, Cockerill FR, et al. Bacteremia due to Enterococcus avium. Clin Infect Dis. 1993;17:1006–11.PubMedCrossRef Patel R, Keating MR, Cockerill FR, et al. Bacteremia due to Enterococcus avium. Clin Infect Dis. 1993;17:1006–11.PubMedCrossRef
7.
go back to reference Facklam RR, Teixeira LM. Enterococcus. In: Lollier L, Balows A, Sussman M, editors. Topley and Wilson’s microbiology and microbial infections. 9th ed. New York: Oxford University Press; 1998. p. 669–82. Facklam RR, Teixeira LM. Enterococcus. In: Lollier L, Balows A, Sussman M, editors. Topley and Wilson’s microbiology and microbial infections. 9th ed. New York: Oxford University Press; 1998. p. 669–82.
8.
go back to reference Papaparaskevas J, Tassios PT, Kalapothaki V, et al. Epidemiology of multiresistant Enterococcus avium isolates in a Greek tertiary care hospital. Int J Antimicrob Agents. 2002;20(6):432–7.PubMedCrossRef Papaparaskevas J, Tassios PT, Kalapothaki V, et al. Epidemiology of multiresistant Enterococcus avium isolates in a Greek tertiary care hospital. Int J Antimicrob Agents. 2002;20(6):432–7.PubMedCrossRef
9.
go back to reference Pearce CL, Evans MK, Peters SM, et al. Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital. Am J Infect Control. 1998;26:563–8.PubMedCrossRef Pearce CL, Evans MK, Peters SM, et al. Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital. Am J Infect Control. 1998;26:563–8.PubMedCrossRef
10.
go back to reference Johnson AP, Warner M, Hallas G, et al. Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin resistant enterococci from the UK, 1997 to mid 1999. J Antimicrob Chemother. 2000;46(1):125–8.PubMedCrossRef Johnson AP, Warner M, Hallas G, et al. Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin resistant enterococci from the UK, 1997 to mid 1999. J Antimicrob Chemother. 2000;46(1):125–8.PubMedCrossRef
11.
go back to reference Orimo H, Yamamoto O, Izu K, et al. Four cases of non-clostridial gas gangrene with diabetes mellitus. J UOEH. 2002;24:55–64.PubMed Orimo H, Yamamoto O, Izu K, et al. Four cases of non-clostridial gas gangrene with diabetes mellitus. J UOEH. 2002;24:55–64.PubMed
12.
go back to reference Mendes JJ, Marques-Costa A, Vilela C, et al. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract. 2012;95:153–61.PubMedCrossRef Mendes JJ, Marques-Costa A, Vilela C, et al. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract. 2012;95:153–61.PubMedCrossRef
Metadata
Title
Enterococcus avium—a rare cause for limb loss in a type 2 diabetic patient
Authors
R. Raja Shanmugakrishnan
Venkatesan Naveenkumar
Krishnan Mahalakshmi
Padma Krishnan
Publication date
01-06-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0318-z

Other articles of this Issue 2/2015

International Journal of Diabetes in Developing Countries 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.